Skip to main content

Peer Review reports

From: Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluation

Original Submission
30 Apr 2022 Submitted Original manuscript
9 May 2022 Reviewed Reviewer Report
28 Jun 2022 Reviewed Reviewer Report
12 Jul 2022 Author responded Author comments - Michael Lowe
Resubmission - Version 2
12 Jul 2022 Submitted Manuscript version 2
Publishing
13 Jul 2022 Editorially accepted
22 Jul 2022 Article published 10.1186/s10194-022-01456-2

You can find further information about peer review here.

Back to article page